Inventor profile of:

Alan Crane

City:

Waban, Massachusetts

Country:

United States

Published Applications:

17

Last publication date:

2024-08-29

Top Assignees for applications by Alan Crane

The entities that hold a legal rights for patent applications filed by inventor Crane Alan:

Recent patent applications by Crane Alan

Alan Crane from Waban, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-08-29
US20240285766A1
Human necessities

Liquid Protein Formulations Containing Ionic Liquids

#2 | 2024-06-06
US20240181063A1
Human necessities

Liquid Protein Formulations Containing Viscosity-Lowering Agents

#3 | 2022-02-10
US20220041713A1
Chemistry; metallurgy

TARGETED IMMUNOTOLERANCE

#4 | 2022-01-06
US20220002409A1
Chemistry; metallurgy

Targeted Immunotolerance

#5 | 2021-03-25
US20210085792A1
Human necessities

Liquid Protein Formulations Containing Viscosity-Lowering Agents

#6 | 2021-02-11
US20210038718A1
Human necessities

Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)

#7 | 2021-02-04
US20210030877A1
Human necessities

Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)

#8 | 2018-09-20
US20180265584A1
Chemistry; metallurgy

Targeted immunotolerance

#9 | 2018-08-16
US20180228831A1
Human necessities

Polysaccharide and nucleic acid formulations containing viscosity-lowering agents

#10 | 2018-06-28
US20180177876A1
Human necessities

Liquid Protein Formulations Containing Thiamine

#11 | 2018-06-28
US20180177875A1
Human necessities

Liquid protein formulations containing cimetidine

#12 | 2018-06-07
US20180153997A1
Human necessities

Liquid protein formulations containing thiamine pyrophosphate (TPP)

#13 | 2018-03-29
US20180085463A1
Human necessities

Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)

#14 | 2015-03-12
US20150071925A1
Human necessities

Liquid pharmaceutical formulations for injection comprising procaine and uses thereof

#15 | 2015-03-12
US20150071922A1
Human necessities

Liquid protein formulations for injection comprising 1-butyl-3-methylimidazolium methanesulfonate and uses thereof

#16 | 2015-03-12
US20150071921A1
Human necessities

Liquid pharmaceutical formulations for injection comprising thiamine pyrophosphate 1-(3-aminopropyl)-2-methyl-1H-imidazole and uses thereof

#17 | 2015-03-12
US20150071920A1
Human necessities

Liquid pharmaceutical formulations for injection comprising yellow 5 or orange G and uses thereof

InventorID:

1095357 ⎘